N

+ Studies in 2000-2009 List
* Studies in Pre-2000 List

NAIL-PATELLA SYNDROME +
NAUSEA*+ (See Also MORNING SICKNESS, MOTION SICKNESS, RADIATION-INDUCED NAUSEA)
NEOINTIMA (Thickening of Arterial Walls)
NEUROGENESIS (Formation of New Neurons)
NEUROMYELITIS OPTICA/DEVICA’S DISEASE (Disorder Causing Swelling of the Eye Nerves)
NEURONS/BRAIN CELLS*+
NEUROPATHIC PAIN*+
NEUROPROTECTION*+
NIEMANN-PICK DISEASE (See Pre-2000 List)
NUTRITION-GENERAL*+ (See Also OMEGA-3/CB1 CONNECTION, METHODS OF USE-EDIBLES)
NUTRITION-HEMP SEED*+
NUTRITION-HEMP SEED OIL*+ (See Also OMEGA-3/CB1 CONNECTION)


NAIL-PATELLA SYNDROME 
Federal Rx: Marijuana (news-2011) http://greencrosscenter.com/marijuana-card-doctor/2011/12/federal-rx-marijuana/
George McMahon (news-2013) http://cannabisnationradio.com/george-mcmahon


NAUSEA
Regulation of nausea and vomiting by cannabinoids (full-2010) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2010.01176.x/pdf
Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomiting (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2997305/pdf/bcp0070-0656.pdf
Mechanisms of Broad-Spectrum Antiemetic Efficacy of Cannabinoids against Chemotherapy-Induced Acute and Delayed Vomiting (link to PDF- 2010) http://www.mdpi.com/1424-8247/3/9/2930
The abuse potential of the synthetic cannabinoid nabilone (abst-2010) http://www.ncbi.nlm.nih.gov/pubmed/20402993
Motion Sickness, Stress and the Endocannabinoid System (abst-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873996/?toolmcentrez
Cannabidiol, a Non-Psychotropic Component of Cannabis, Attenuates Vomiting and Nausea-like Behaviour via Indirect Agonism of 5-HT(1A) Somatodendritic: Autoreceptors in the Dorsal Raphe Nucleus (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423241/
Medical Marijuana: Can Pot Help Pregnant Women With Vomiting and Nausea? (article-2011) http://patients4medicalmarijuana.wordpress.com/2011/01/13/pregnancy-and-medical-marijuana-can-pothelp-pregnant-women-with-vomiting-and-nausea/
Interaction between non-psychotropic cannabinoids in marihuana: effect of cannabigerol (CBG) on the anti-nausea or anti-emetic effects of cannabidiol (CBD) in rats and shrews (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21243485
How Does Marijuana Help Cancer Patients? (news-2011) http://www.livestrong.com/article/219707-how-does-marijuana-help-cancer-patients/
top
Medical Marijuana: Clearing Away the Smoke (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3358713/
Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid? (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579248/
The anti-nausea effects of CB(1) agonists are mediated by an action at the visceral insular cortex (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3492992/
The Therapeutic Potential of Cannabis and Cannabinoids (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442177/
Tumor necrosis factor activation of vagal afferent terminal calcium is blocked by cannabinoids (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342927/
Cannabidiolic acid prevents vomiting in Suncus murinus and nausea-induced behaviour in rats by enhancing 5-HT(1A) receptor activation (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596650/
Cannabinoids in the treatment of chemotherapy-induced nausea and vomiting (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22491047
Effects of parabolic flight and spaceflight on the endocannabinoid system in humans (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23023882
Effects of dronabinol on morphine-induced dopamine-related behavioral effects in animals (abst–2012) http://onlinelibrary.wiley.com/doi/10.1002/syn.21586/abstract
New Study Says Marijuana Could Stop Cancer from Spreading (news–2012) http://www.opposingviews.com/i/society/drug-law/new-study-adds-research-showing-marijuana-couldstop-cancer
Cannabis as Painkiller (news – 2012) http://www.sciencedaily.com/releases/2012/08/120807101232.htm
Therapeutic potential of cannabinoid medicines (full–2013) http://onlinelibrary.wiley.com/doi/10.1002/dta.1529/full
Effect of low doses of cannabidiolic acid and ondansetron on LiCl-induced conditioned gaping (a model of nausea-induced behaviour) in rats (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3682714/
Additive antiemetic efficacy of 9-THC with vanilloid TRPV1 receptor agonists in the least shrew (Cryptotis parva) (abst–2013) http://www.fasebj.org/cgi/content/meeting_abstract/27/1_MeetingAbstracts/1093.20?sid=eea722c0-971c-4daa-8b8c-38c0c63c19ad
Evaluation of the potential of the phytocannabinoids, cannabidivarin (CBDV) and Δ9 -tetrahydrocannabivarin (THCV), to produce CB1 receptor inverse agonism symptoms of nausea in rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23902479
2-arachidonoylglycerol interferes with lithium-induced vomiting in the house musk shrew, Suncus murinus (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23958470
Anandamide transport inhibition by ARN272 attenuates nausea-induced behaviour in rats, and vomiting in shrews (Suncus murinus) (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23991698
Dronabinol Treatment of Refractory Nausea and Vomiting Related to Peritoneal Carcinomatosis (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24052427
Additive antiemetic efficacy of low-doses of the cannabinoid CB1/2 receptor agonist Δ9-THC with ultralow-doses of the vanilloid TRPV1 receptor agonist resiniferatoxin in the least shrew (Cryptotis parva) (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24157976
Regulation of nausea and vomiting by cannabinoids and the endocannabinoid system (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24184696
Suppression of lithium chloride-induced conditioned gaping (a model of nausea-induced behaviour) in rats (using the taste reactivity test) with metoclopramide is enhanced by cannabidiolic acid (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24012649
top
Tetrahydrocannabinolic acid reduces nausea-induced conditioned gaping in rats and vomiting in Suncus murinus (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23889598
Dexamethasone alleviates motion sickness in rats in part by enhancing the endocannabinoid system (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24508383
A comparison of cannabidiolic acid with other treatments for anticipatory nausea using a rat model of contextually elicited conditioned gaping (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24595502
Toward modulation of the endocannabinoid system for treatment of gastrointestinal disease: FAAHster but not “higher” (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24641009
(Mo1122) Prevalence and Characterization of Cannabinoid Use in Patients With Gastrointestinal Disorders (abst-2014) http://www.gastrojournal.org/article/S0016-5085%2814%2962037-0/pdf
Meta-analysis of adjunctive non-NK1 receptor antagonist medications for the control of acute and delayed chemotherapy-induced nausea and vomiting (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25145507
Effect of selective inhibition of monoacylglycerol lipase (MAGL) on acute nausea, anticipatory nausea, and vomiting in rats and Suncus murinus (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25085768
Medical marijuana: more questions than answers (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25226202
Therapeutic Potential of Cannabinoids in Counteracting Chemotherapy-induced Adverse Effects: An Exploratory Review (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25504799
Potential applications of marijuana and cannabinoids in medicine (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25518584
Low or No THC, High CBD Medical Marijuana Bills: Leaving Most Patients Behind (news-2014) http://www.mpp.org/assets/documents/low-or-no-thc-high-cbd.html
Intra-visceral insular cortex 2-arachidonoylglycerol, but not N arachidonoylethanolamide, suppresses acute nausea-induced conditioned gaping in rats (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25499318
Novel associations between FAAH genetic variants and postoperative central opioid related adverse effects (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25558980
The successful use of dronabinol for failure to thrive secondary to intestinal dysmotility (full-2015) http://www.casereports.com/article/S2210-2612%2815%2900219-9/pdf
Cannabis in cancer care (full-2015) http://onlinelibrary.wiley.com/doi/10.1002/cpt.108/full
Cannabinoid hyperemesis syndrome: Marijuana is both antiemetic and proemetic (full-2015) http://www.ccjm.org/index.php?id=107953&tx_ttnews%5Btt_news%5D=412809&cHash=0c1f8670f2fa499ee88aeff79ee2a47e
Medical marijuana: Hints of headway? Despite a conflicted regulatory landscape, support for medical marijuana is growing amid increasing evidence of potential benefits (Part 2 of 2) (article-2015) http://onlinelibrary.wiley.com/doi/10.1002/cncy.21524/full
Medical Marijuana: Is the Cart Before the Horse? (1st page-2015) http://jama.jamanetwork.com/article.aspx?articleid=2338230
Intra-visceral insular cortex 2-arachidonoylglycerol, but not Narachidonoylethanolamide, suppresses acute nausea-induced conditioned gaping in rats (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25499318
Novel associations between FAAH genetic variants and postoperative central opioidrelated adverse effects (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25558980
top
The role of cannabinoids in regulation of nausea and vomiting, and visceral pain (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25715910
Cannabinoids suppress acute and anticipatory nausea in pre-clinical rat models of conditioned gaping. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25691302
Synergy between cannabidiol, cannabidiolic acid, and Δ⁹-tetrahydrocannabinol in the regulation of emesis in the Suncus murinus (house musk shrew). (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/26030435
UEA scientists separate medical benefits of cannabis from unwanted side effects (news – 2015) http://www.alphagalileo.org/ViewItem.aspx?ItemId=154355&CultureCode=en
Huge New Review Shows What Medical Marijuana May (and May Not) Help (news – 2015) https://www.yahoo.com/health/huge-new-review-shows-what-medical-marijuana-may-122209836947.html
Marijuana Is a Wonder Drug When It Comes to the Horrors of Chemo (news – 2015) http://www.newsweek.com/2015/07/31/keep-toke-alive-356032.html


NEOINTIMA 
Targeting cannabinoid receptor CB2 in cardiovascular disorders: promises and controversies (full-2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02042.x/pdf
Cannabinoid receptor CB2 protects against balloon-induced neointima formation (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3774259/
Endogenous cannabinoid receptor CB1 activation promotes vascular smooth muscle cell proliferation and neointima formation (full-2013) http://www.jlr.org/content/early/2013/03/11/jlr.M035147.long
Magnolol inhibits migration of vascular smooth muscle cells via cytoskeletal remodeling pathway to attenuate neointima formation (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/23906924


NEUROGENESIS 
Cannabinoid receptor CB1 mediates baseline and activity-induced survival of new neurons in adult hippocampal neurogenesis (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2898685/?tool=pmcentrez
Loss of retrograde endocannabinoid signaling and reduced adult neurogenesis in diacylglycerol lipase knock-out mice (full-2010) http://www.jneurosci.org/content/30/6/2017.long
Converging action of alcohol consumption and cannabinoid receptor activation on adult hippocampal neurogenesis (full-2010) http://ijnp.oxfordjournals.org/content/13/2/191.long
CB1 receptor deficiency decreases wheel-running activity: consequences on emotional behaviours and hippocampal neurogenesis (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/20138171
Cannabidiol Reduces Aβ-Induced Neuroinflammation and Promotes Hippocampal Neurogenesis through PPARγ Involvement (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3230631/?tool=pubmed
CB2 Cannabinoid Receptors Promote Neural Progenitor Cell Proliferation via mTORC1 Signaling (full-2011) http://www.jbc.org/content/287/2/1198.full
top
Can the benefits of cannabinoid receptor stimulation on neuroinflammation, neurogenesis and memory during normal aging be useful in AD prevention? (full-2012) http://www.jneuroinflammation.com/content/9/1/10
Endocannabinoids via CB₁ receptors act as neurogenic niche cues during cortical development (full-2012) http://rstb.royalsocietypublishing.org/content/367/1607/3229.long
Relationships between dietary macronutrients and adult neurogenesis in the regulation of energy metabolism (full-2013) http://journals.cambridge.org/action/displayFulltext?type=6&fid=8904779&jid=BJN&volumeId=109&issueId=09&aid=8904778&bodyId=&membershipNumber=&societyETOCSession=&fulltextType=RV&fileId=S000711451200579X
Cannabinoids, Neurogenesis and Antidepressant Drugs: Is there a Link? (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3648779/
Activation of Type 1 Cannabinoid Receptor (CB1R) Promotes Neurogenesis in Murine Subventricular Zone Cell Cultures (full-2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0063529
The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/23298518
Neuroimmmune interactions of cannabinoids in neurogenesis: focus on interleukin-1β (IL-1β) signalling (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/24256257
CB2 cannabinoid agonist enhanced neurogenesis in GFAP/Gp120 transgenic mice displaying deficits in neurogenesis (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/24148086
High hopes for CB(2) receptors in neurogenesis (full-2014) http://onlinelibrary.wiley.com/doi/10.1111/bph.12548/full
Impaired Neurogenesis by HIV-1-Gp120 is Rescued by genetic deletion of Fatty Acid Amide Hydrolase Enzyme (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24571443
Blockade of 2-arachidonoylglycerol hydrolysis produces antidepressant-like effects and enhances adult hippocampal neurogenesis and synaptic plasticity (full-2015) http://onlinelibrary.wiley.com/doi/10.1002/hipo.22344/full
The role of cannabinoids in adult neurogenesis (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25951750
Influence of single and repeated cannabidiol administration on emotional behavior and markers of cell proliferation and neurogenesis in non-stressed mice (abst-2015) http://www.sciencedirect.com/science/article/pii/S027858461530004X
ACEA (a highly selective cannabinoid CB1 receptor agonist) stimulates hippocampal neurogenesis in mice treated with antiepileptic drugs (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26225920


NEUROMYELITIS OPTICA/DEVICA’S DISEASE
The major brain endocannabinoid 2-AG controls neuropathic pain and mechanical hyperalgesia in patients with neuromyelitis optica (full-2012) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0071500
top


NEURONS/BRAIN CELLS
Cyclooxygenase-2 Mediates Anandamide Metabolism in the Mouse Brain (full-2010) http://jpet.aspetjournals.org/content/335/2/380.full?sid=af53ea87-ab4b-426e-9c7e-8f750e9c4a17
Cannabinoids Excite Circadian Clock Neurons (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2927117/?toolmcentrez
Cannabinoid receptor CB1 mediates baseline and activity-induced survival of new neurons in adult hippocampal neurogenesis (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2898685/?toolmcentrez
Delta9-tetrahydrocannabinol is a full agonist at CB1 receptors on GABA neuron axon terminals in the hippocampus (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2882293/pdf/nihms200194.pdf
AAV vector-mediated overexpression of CB1 cannabinoid receptor in pyramidal neurons of the hippocampus protects against seizure-induced excitoxicity (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3006205/?toolubmed
Sex difference in cell proliferation in developing rat amygdala mediated by endocannabinoids has implications for social behavior (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2996668/?toolubmed
CB1 cannabinoid receptors increase neuronal precursor proliferation through AKT/glycogen synthase kinase-3beta/beta-catenin signaling (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2843172/?toolubmed
Cannabidiol protects retinal neurons by preserving glutamine synthetase activity in diabetes (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2925907/?toolubmed
Endocannabinoids Prevent β-Amyloid-mediated Lysosomal Destabilization in Cultured Neurons (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2992287/
Regulatory Role of Cannabinoid Receptor 1 in Stress-Induced Excitotoxicity and Neuroinflammation (full-2010) http://www.nature.com/npp/journal/vaop/ncurrent/full/npp2010214a.html
Endocannabinoids: Going retro with DAGLα (article-2010) http://www.lipidmaps.org/update/2010/100401/full/nrn2824.html?s=cannabinoid
Palmitoylethanolamide and other anandamide congeners. Proposed role in the diseased brain. (abst-2010) http://www.ncbi.nlm.nih.gov/pubmed/20353771
PP-014 Control of receptor expression in vagal afferent neurons by activation of cannabinoid 1 receptors (abst–2010) http://gut.bmj.com/cgi/content/meeting_abstract/59/1_MeetingAbstracts/A45-a?sid=0731f0e5-2071-4549-be57-57f444307138
Protective effects of the synthetic cannabinoids CP55,940 and JWH-015 on rat brain mitochondria upon paraquat exposure (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20514518
Cannabidiol Reduces Aβ-Induced Neuroinflammation and Promotes Hippocampal Neurogenesis through PPARγ Involvement (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3230631/?toolubmed
A synaptogenic amide N-docosahexaenoylethanolamide promotes hippocampal development (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3215906/
A catalytically silent FAAH-1 variant drives anandamide transport in neurons. (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3245783/
Sex difference in cell proliferation in developing rat amygdala mediated by endocannabinoids has implications for social behavior (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2996668/?toolubmed
top
Dual inhibition of alpha/beta hydrolase domain 6 and fatty acid amide hydrolase increases endocannabinoid levels in neurons (full–2011) http://www.jbc.org/content/early/2011/06/10/jbc.M110.202853.long
Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249428/
CNS effects of CB2 cannabinoid receptors: beyond neuro-immuno-cannabinoid activity (full–2011) http://jop.sagepub.com/content/26/1/92.full
Activation of cannabinoid type 2 receptors inhibits HIV-1 envelope glycoprotein gp120-induced synapse loss (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3164336/
Cannabinoid receptor-mediated regulation of neuronal activity in the main olfactory bulb (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3397690/
Cannabinoid receptor agonist protects cultured dopaminergic neurons from the death by the proteasomal dysfunction (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3145842/?toolubmed
CB2 Cannabinoid Receptors Promote Neural Progenitor Cell Proliferation via mTORC1 Signaling (full–2011) http://www.jbc.org/content/287/2/1198.full
History of cannabis use is not associated with alterations in striatal dopamine D2/D3 receptor availability (full–2011) http://jop.sagepub.com/content/26/1/144.long
HIV-1 infection and alcohol abuse: neurocognitive impairment, mechanisms of neurodegeneration and therapeutic interventions (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3098312/
Cannabinoid Receptor Type 1 Protects Nigrostriatal Dopaminergic Neurons against MPTP Neurotoxicity by Inhibiting Microglial Activation (full-2011) http://www.jimmunol.org/content/187/12/6508.full?sid=c3422dd2-7ad0-42e4-a862-845dc670f7cf
Endocannabinoid 2-arachidonoylglycerol protects neurons against β-amyloid insults (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3052737/pdf/nihms266962.pdf
The Dopamine and Cannabinoid Interaction in the Modulation of Emotions and Cognition: Assessing the Role of Cannabinoid CB1 Receptor in Neurons Expressing Dopamine D1 Receptors. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3156975/
Pharmacological activation/inhibition of the cannabinoid system affects alcohol withdrawal-induced neuronal hypersensitivity to excitotoxic insults. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3158793/
Endocannabinoid signaling in the amygdala: anatomy, synaptic signaling, behavior, and adaptations to stress (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3236282/
Synaptic plasticity: A new partnership (article – 2011) http://www.lipidmaps.org/update/2011/110201/full/nrn2972.html?s=cannabinoid
The Effect of Hypoxia on G Protein Coupled (CB1) Receptor Gene Expression in Cortical B50 Neurons in Culture (abst–2011) http://www.maxwellsci.com/jp/abstract.php?jid=BJPT&no=92&abs=05
The G protein-coupled cannabinoid-1 (CB(1)) receptor of mammalian brain: Inhibition by phthalate esters in vitro (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21763743
α-Tocopherol and α-tocopheryl phosphate interact with the cannabinoid system in the rodent hippocampus (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21843633
Effects of synthetic cannabinoids on electroencephalogram power spectra in rats (abst-2011) http://www.unboundmedicine.com/medline/ebm/record/21640532/abstract/Effects_of_synthetic_cannabinoids_on_electroencephalogram_power_spectra_in_rats_
top
Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21278728
Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions. Figure 1: n-3/n-6 PUFA dietary imbalance alters PUFAs level in mouse brain (charts-2011) http://www.nature.com/neuro/journal/v14/n3/fig_tab/nn.2736_F1.html
Δ(9)-THC and WIN55,212-2 affect brain tissue levels of excitatory amino acids in a phenotype-, compound-, dose-, and region-specific manner (abst-2011) http://www.unboundmedicine.com/medline/ebm/record/21645556/abstract/%CE%94_9__THC_and_WIN55212_2_affect_brain_tissue_levels_of_excitatory_amino_acids_in_a_phenotype__compound__dose__and_region_specific_manner_
A Brain Wrought Without Omega-3 (news–2011) http://www.schizophreniaforum.org/new/detail.asp?id=1646
Endocannabinoids in nervous system health and disease: the big picture in a nutshell (full-2012) http://rstb.royalsocietypublishing.org/content/367/1607/3193.long
Role of CB1 cannabinoid receptors on GABAergic neurons in brain aging (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3131310/?toolubmed
Type-1 Cannabinoid Receptor Signaling in Neuronal Development (full-2012) http://content.karger.com/produktedb/produkte.asp?DOI=000339075&typdf
Cortisol-mediated adhesion of synovial fibroblasts is dependent on the degradation of anandamide and activation of the endocannabinoid system (full–2012) http://onlinelibrary.wiley.com/doi/10.1002/art.37684/pdf
Synaptic Targets of Δ9-Tetrahydrocannabinol in the Central Nervous System (full-2012) http://perspectivesinmedicine.cshlp.org/content/early/2012/12/03/cshperspect.a012237.long
Endocannabinoids and the processing of value-related signals (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3270484/?toolubmed
Neuron to Astrocyte Communication via Cannabinoid Receptors Is Necessary for Sustained Epileptiform Activity in Rat Hippocampus (full–2012) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0037320
Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-α. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3315437/?toolubmed
Review article: The endocannabinoid system in normal and pathological brain ageing (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3326.full?sid=161e7b36-5055-448b-962e-697c782e901d
Excitability of prefrontal cortical pyramidal neurons is modulated by activation of 98 intracellular type-2 cannabinoid receptors (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3295302/
Intrinsic Up-Regulation of 2-AG Favors an Area Specific Neuronal Survival in Different In Vitro Models of Neuronal Damage (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3527460/
Functional diversity on synaptic plasticity mediated by endocannabinoids (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3481528/
The CB(2)-preferring agonist JWH015 also potently and efficaciously activates CB(1) in autaptic hippocampal neurons (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601544/
Long-lasting potentiation of hippocampal synaptic transmission by direct cortical input is mediated via endocannabinoids (full-2012) http://jp.physoc.org/content/590/10/2305.full
The CB1 Cannabinoid Receptor Drives Corticospinal Motor Neuron Differentiation through the Ctip2/Satb2 Transcriptional Regulation Axis (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3545190/
top
A cell population that strongly expresses the CB1 cannabinoid receptor in the ependyma of the rat spinal cord (abst–2012) http://www.biomedexperts.com/Abstract.bme/22791629/A_cell_population_that_strongly_expresses_the_CB1_cannabinoid_receptor_in_the_ependyma_of_the_rat_spinal_cord
Mitochondrial CB(1) receptors regulate neuronal energy metabolism (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22388959
Effects of cannabinoids Δ(9)-tetrahydrocannabinol, Δ(9)-tetrahydrocannabinolic acid and cannabidiol in MPP(+) affected murine mesencephalic cultures (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22571976
Cannabinoid modulation of midbrain urocortin 1 neurones during acute and chronic stress (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22734681
Manipulating brain connectivity with δ(9)-tetrahydrocannabinol: A pharmacological resting state FMRI study (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22885247
Cannabinoid CB(1) receptor in the modulation of stress coping behaviour in mice: the role of serotonin and different forebrain neuronal subpopulations (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/23000076
Multiple functions of endocannabinoid signaling in the brain (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22524785?dopt=Abstract
The role of endocannabinoids in pain modulation (full-2013) http://onlinelibrary.wiley.com/doi/10.1111/fcp.12008/pdf
Type-1 (CB(1)) Cannabinoid Receptor Promotes Neuronal Differentiation and Maturation of Neural Stem Cells (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0054271
Orexin neurons use endocannabinoids to break obesity-induced inhibition (full–2013) http://www.pnas.org/content/110/24/9625.full
Signaling Pathways Involved in Striatal Synaptic Plasticity are Sensitive to Temporal Pattern and Exhibit Spatial Specificity (full–2013) http://www.ploscompbiol.org/article/info%3Adoi%2F10.1371%2Fjournal.pcbi.1002953
A biophysical model of endocannabinoid-mediated short term depression in hippocampal inhibition (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0058926
The endocannabinoid system, cannabinoids, and pain (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820295/
Activation of Type 1 Cannabinoid Receptor (CB1R) Promotes Neurogenesis in Murine Subventricular Zone Cell Cultures (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0063529
N-arachidonoyl-L-serine (AraS) possesses proneurogenic properties in vitro and in vivo after traumatic brain injury (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3734775/
HINT1 protein cooperates with cannabinoid 1 receptor to negatively regulate glutamate NMDA receptor activity (full–2013) http://www.molecularbrain.com/content/6/1/42
Obesity-driven synaptic remodeling affects endocannabinoid control of orexinergic neurons (full–2013) http://www.pnas.org/content/110/24/E2229.full
Cannabinoid- and lysophosphatidylinositol-sensitive receptor GPR55 boosts neurotransmitter release at central synapses (full–2013) http://www.pnas.org/content/early/2013/03/06/1211204110.full.pdf+html
Stimulatory and Inhibitory Roles of Brain 2-Arachidonoylglycerol in Bombesin-Induced Central Activation of Adrenomedullary Outflow in Rats (full–2013) https/www.jstage.jst.go.jp/article/jphs/121/2/121_12208FP/_pdf
Association between a genetic variant of type-1 cannabinoid receptor and inflammatory neurodegeneration in multiple sclerosis (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877004/
top
Food for thought: hormonal, experiential, and neural influences on feeding and obesity (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3818543/
Neuroprotective effects of Cannabis sativa leaves extracts on α-Motoneurons density after sciatic nerve injury in rats (full–2013) http://www.lifesciencesite.com/lsj/life1005s/113_15973life1005s_644_648.pdf
Neuron-type specific cannabinoid-mediated G protein signalling in mouse hippocampus (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/jnc.12137/full
Diacylglycerol Lipaseα (DAGLα and DAGLβ Cooperatively Regulate the Production of 2-Arachidonoyl Glycerol in Autaptic Hippocampal Neurons (full–2013) http://molpharm.aspetjournals.org/content/84/2/296.full.pdf+html
CB2 Receptor Agonists Protect Human Dopaminergic Neurons against Damage from HIV-1 gp120 (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0077577
Astroglial CB1 cannabinoid receptors regulate leptin signaling in mouse brain astrocytes (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3854987/
Sex-specific tonic 2-arachidonoylglycerol signaling at inhibitory inputs onto dopamine neurons of Lister Hooded rats (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3867690/
Insulin induces long-term depression of VTA dopamine neurons via endocannabinoids (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072656/
Rapid Glucocorticoid-Induced Activation of TRP and CB1 Receptors Causes Biphasic Modulation of Glutamate Release in Gastric-Related Hypothalamic Preautonomic Neurons (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3560102/
Activation-dependent plasticity of polarized GPCR distribution on the neuronal surface (full–2013) http://jmcb.oxfordjournals.org/content/5/4/250.long
The neuroprotective role of endocannabinoids against chemical-induced injury and other adverse effects (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23296873
CB1 Cannabinoid Receptors Promote Maximal FAK Catalytic Activity By Stimulating Cooperative Signaling Between Receptor Tyrosine Kinases and Integrins in Neuronal Cells (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23571270
2-AG into the lateral hypothalamus increases REM sleep and cFos expression in melanin concentrating hormone neurons in rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23603032
Acute inhibition of diacylglycerol lipase blocks endocannabinoid-mediated retrograde synaptic suppression: evidence for on-demand biosynthesis of 2-arachidonoylglycerol. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23858009
The satiety signal oleoylethanolamide stimulates oxytocin neurosecretion from rat hypothalamic neurons. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23959001
Anandamide produced by Ca2+-insensitive enzymes induces excitation in primary sensory neurons. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24114173
CB2 cannabinoid agonist enhanced neurogenesis in GFAP/Gp120 transgenic mice displaying deficits in neurogenesis. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24148086
Optogenetic identification of an intrinsic cholinergically driven inhibitory oscillator sensitive to cannabinoids and opioids in hippocampal CA1 (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24190932
top
Cytotoxicity of synthetic cannabinoids on primary neuronal cells of the forebrain: the involvement of cannabinoid CB1 receptors and apoptotic cell death (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24211273
Glutamate spillover drives endocannabinoid production and inhibits GABAergic transmission in the Substantia Nigra pars compacta (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24334069
Marijuana cannabinoids slow brain degradation and aging, reverse dementia: here’s how (news–2013) http://www.naturalnews.com/040456_marijuana_cannabinoids_dementia.html
5 Health Benefits Of Cannabichromene (CBC) (news – 2013) http://www.leafscience.com/2013/09/21/5-health-benefits-of-cannabichromene-cbc/
Δ(9)-THC and N-arachidonoyl glycine regulate BV-2 microglial morphology and cytokine release plasticity: implications for signaling at GPR18 (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877838/
Presynaptic mechanisms of neuronal plasticity and their role in epilepsy (full–2014) http://journal.frontiersin.org/Journal/10.3389/fncel.2014.00164/full
Endogenous Signaling by Omega-3 Docosahexaenoic Acid-derived Mediators Sustains Homeostatic Synaptic and Circuitry Integrity (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180614/
Cannabinoid, melanocortin and opioid receptor expression on DRD1 and DRD2 subpopulations in rat striatum (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3972466/
Anandamide in primary sensory neurons: too much of a good thing? (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24494681
Trans-Caryophyllene Suppresses Hypoxia-Induced Neuroinflammatory Responses by Inhibiting NF-κB Activation in Microglia. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24488604
Endocannabinoid 2-Arachidonylglycerol Protects Primary Cultured Neurons Against LPS-Induced Impairments in Rat Caudate Nucleus. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24510751
Endocannabinoids in Synaptic Plasticity and Neuroprotection (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24571856
Cellular approaches to the interaction between cannabinoid receptor ligands and nicotinic acetylcholine receptors (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24642359
Control of Inhibition by the Direct Action of Cannabinoids on GABAA Receptors (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24646614
Mechanisms of synaptic dysfunction and excitotoxicity in Huntington’s disease (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24603212
Prior stimulation of the endocannabinoid system prevents methamphetamine-induced dopaminergic neurotoxicity in the striatum through activation of CB2 receptors. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24709540
Endocannabinoid-mediated retrograde modulation of synaptic transmission (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24747340
Inhibition of Peripheral Fatty Acid Amide Hydrolase Depresses Activities of Bladder Mechanosensitive Nerve Fibers of the Rat (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24746881
Effect of N-Arachidonoyl Dopamine on Activity of Neuronal Network in Primary Hippocampus Culture upon Hypoxia Modelling (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24771427
Roles of fatty acid ethanolamides (FAE) in traumatic and ischemic brain injury. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24874648
Morphological and Behavioural Evidence for Impaired Prefrontal Cortical Function in Female CB1 Receptor Deficient Mice. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24907533
top
β-Amyloid Inhibits E-S Potentiation through Suppression of Cannabinoid Receptor 1- Dependent Synaptic Disinhibition. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24945775
Detection of cannabinoid receptors CB1 and CB2 within basal ganglia output neurons in macaques: changes following experimental parkinsonism. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24972960
Endocannabinoid signaling modulates neurons of the pedunculopontine nucleus (PPN) via astrocytes. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25009314
Cannabinoid Receptor-2 and HIV-Associated Neurocognitive Disorders. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25015040
Cannabinoid receptor intracellular signalling: The long journey from binding sites to biological effects (abst – 2014) http://onlinelibrary.wiley.com/doi/10.1002/9781118451281.ch2/summary
Endocannabinoid modulation by FAAH and MAGL within the analgesic circuitry of the periaqueductal grey. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25041240
Fatty Acid-binding Protein 5 (FABP5) Regulates Cognitive Function Both by Decreasing Anandamide Levels and by Activating the Nuclear Receptor Peroxisome Proliferatoractivated Receptor β/δ (PPARβ/δ in the Brain (abst – 2014) http://www.jbc.org/content/289/18/12748.abstract?sid=58027e04-8d1d-47c5-b6d3-49611e578de4
Cannabinoid Receptor Type 2 Agonist Attenuates Apoptosis by Activation of Phosphorylated CREB-Bcl-2 Pathway After Subarachnoid Hemorrhage in Rats (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25058046
The Neurobiology of Cancer Pain (abst–2014) http://nro.sagepub.com/content/early/2014/03/24/1073858414525828.abstract
The interaction between serotonergic and cannabinoidergic modulations involved in the fear extinction (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25069241
Activation of CB1 inhibits NGF-induced sensitization of TRPV1 in adult mouse afferent neurons (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25088915
Descending modulation of pain: the GABA disinhibition hypothesis of analgesia (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25064178
Chronic cannabinoid receptor stimulation selectively prevents motor impairments in a mouse model of Huntington’s disease (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25123645
Marijuana’s anxiety relief effects: Receptors found in emotional hub of brain (news-2014) http://www.sciencedaily.com/releases/2014/03/140306142803.htm
Active endocannabinoids are secreted on extracellular membrane vesicles (abst-2015) http://embor.embopress.org/content/early/2015/01/07/embr.201439668
On the Role of Astroglial Syncytia in Self-Repairing Spiking Neural Networks (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25576582
Cannabinoid agonists rearrange synaptic vesicles at excitatory synapses and depress motoneuron activity in vivo (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25595101
N-stearoyltyrosine protects primary cortical neurons against Aβ(1-40)-induced injury through inhibiting endocannabinoid degradation (abst-2015) http://www.sciencedirect.com/science/article/pii/S0024320515000521
Opposite control of frontocortical 2-arachidonoylglycerol turnover rate by cannabinoid type-1 (CB1 ) receptors located on glutamatergic neurons and on astrocytes (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25626460
top
How Medical Marijuana’s Chemicals May Protect Cells (news-2015) http://www.scientificamerican.com/article/how-medical-marijuana-s-chemicals-may-protect-cells/
Augmented Inhibition from Cannabinoid-Sensitive Interneurons Diminishes CA1 Output after Traumatic Brain Injury (full-2015) http://journal.frontiersin.org/Journal/10.3389/fncel.2014.00435/full
Blockade of monoacylglycerol lipase inhibits oligodendrocyte excitotoxicity and prevents demyelination in vivo (full-2015) http://onlinelibrary.wiley.com/doi/10.1002/glia.22742/full
Cocaine-induced endocannabinoid release modulates behavioral and neurochemical sensitization in mice (full – 2015) http://onlinelibrary.wiley.com/doi/10.1111/adb.12080/full
Cannabinoid receptor 1 signaling in cardiovascular regulating nuclei in the brainstem: A review. (full – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25685481
Genetic Dissection of Behavioural and Autonomic Effects of Δ9-Tetrahydrocannabinol in Mice (full – 2015) http://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.0050269
The Combined Inhibitory Effect of the Adenosine A1 and Cannabinoid CB1 Receptors on cAMP Accumulation in the Hippocampus Is Additive and Independent of A1 Receptor Desensitization. (full – 2015) http://www.hindawi.com/journals/bmri/2015/872684/
Drugs of Abuse in HIV infection and neurotoxicity (full – 2015) http://journal.frontiersin.org/article/10.3389/fmicb.2015.00217/full
Negative Regulation of Leptin-induced ROS Formation by CB1 Receptor Activation in Hypothalamic Neurons. (full – 2015) http://www.jbc.org/content/early/2015/04/13/jbc.M115.646885.full.pdf+html
WIN 55,212-2, Agonist of Cannabinoid Receptors, Prevents Amyloid β1-42 Effects on Astrocytes in Primary Culture. (full – 2015) http://www.plosone.org/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0122843&representation=PDF
Exposure to Allergen Causes Changes in NTS Neural Activities after Intratracheal Capsaicin Application, in Endocannabinoid Levels and in the Glia Morphology of NTS (full – 2015) http://www.hindawi.com/journals/bmri/2015/980983/
Promising cannabinoid-based therapies for Parkinson’s disease: motor symptoms to neuroprotection. (full – 2015) http://www.molecularneurodegeneration.com/content/pdf/s13024-015-0012-0.pdf
Role for Endogenous BDNF in Endocannabinoid-Mediated Long-Term Depression at Neocortical Inhibitory Synapses (full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4415885/
Sex-dependent vulnerability to Cannabis abuse in adolescence (full – 2015) http://journal.frontiersin.org/article/10.3389/fpsyt.2015.00056/full
Involvement of GluR2 up-regulation in neuroprotection by electroacupuncture pretreatment via cannabinoid CB1 receptor in mice. (full – 2015) http://www.nature.com/srep/2015/150330/srep09490/full/srep09490.html
Effects of high-fructose diets on central appetite signaling and cognitive function (full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429636/
Rapid Non-Genomic Glucocorticoid Actions in Male Mouse Hypothalamic Neuroendocrine Cells Are Dependent on the Nuclear Glucocorticoid Receptor (full – 2015) http://press.endocrine.org/doi/pdf/10.1210/en.2015-1273
The CB1 cannabinoid receptor signals striatal neuroprotection via a PI3K/Akt/mTORC1/BDNF pathway. (full – 2015) http://www.nature.com/cdd/journal/vaop/ncurrent/full/cdd201511a.html
Cannabinoid CB2 Receptors in a Mouse Model of Aβ Amyloidosis: Immunohistochemical Analysis and Suitability as a PET Biomarker of Neuroinflammation (full – 2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0129618
top
Palmitoylethanolamide Inhibits Glutamate Release in Rat Cerebrocortical Nerve Terminals. (full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4394492/
Tonic endocannabinoid-mediated modulation of GABA release is independent of the CB1 content of axon terminals. (full – 2015) http://www.nature.com/ncomms/2015/150420/ncomms7557/full/ncomms7557.html
Anandamide, Acting via CB2 Receptors, Alleviates LPS-Induced Neuroinflammation in Rat Primary Microglial Cultures. (full – 2015) http://www.hindawi.com/journals/np/2015/130639/
Hypothalamic POMC neurons promote cannabinoid-induced feeding (full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496586/
Changes in the endocannabinoid signaling system in CNS structures of TDP-43 transgenic mice: relevance for a neuroprotective therapy in TDP-43-related disorders (full – 2015) http://tinyurl.com/p9zpl2d
Homeostatic regulation of brain functions by endocannabinoid signaling (full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468750/
Metabolic Interplay between Astrocytes and Neurons Regulates Endocannabinoid Action (full – 2015) http://www.cell.com/cell-reports/fulltext/S2211-1247%2815%2900725-1
Impaired 2-AG signaling in hippocampal glutamatergic neurons: aggravation of anxietylike behavior and unaltered seizure susceptibility. (full – 2015) http://ijnp.oxfordjournals.org/content/ijnp/early/2015/07/29/ijnp.pyv091.full.pdf
Multiple Forms of Endocannabinoid and Endovanilloid Signaling Regulate the Tonic Control of GABA Release (full – 2015) http://www.jneurosci.org/content/35/27/10039.full?sid=7e769d1b-9b77-42fe-92d0-8b337b34b9b6
Active endocannabinoids are secreted on extracellular membrane vesicles (abst – 2015) http://embor.embopress.org/content/early/2015/01/07/embr.201439668
On the Role of Astroglial Syncytia in Self-Repairing Spiking Neural Networks (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25576582
Cannabinoid agonists rearrange synaptic vesicles at excitatory synapses and depress motoneuron activity in vivo (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25595101
N-stearoyltyrosine protects primary cortical neurons against Aβ(1-40)-induced injury through inhibiting endocannabinoid degradation (abst-2015)
http://www.sciencedirect.com/science/article/pii/S0024320515000521
Opposite control of frontocortical 2-arachidonoylglycerol turnover rate by cannabinoid type-1 (CB1 ) receptors located on glutamatergic neurons and on astrocytes (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25626460
cnrip1 is a regulator of eye and neural development in Xenopus laevis (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25652037
A Synthetic Cannabinoid MAM-2201 Potently Suppresses Synaptic Transmission via Activation of Presynaptic CB1 Receptors and Reduces Synaptically-Evoked Intracellular Ca2+ Transients in Cerebellar Purkinje Cells (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25747605
Phenotype-dependent inhibition of glutamatergic transmission on nucleus accumbens medium spiny neurons by the abused inhalant toluene (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25752326
VGluT3-Expressing CCK-Positive Basket Cells Construct Invaginating Synapses Enriched with Endocannabinoid Signaling Proteins in Particular Cortical and Cortex-Like Amygdaloid Regions of Mouse Brains (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25762668
Spinal neuronal cannabinoid receptors mediate urodynamic effects of systemic fatty acid amide hydrolase (FAAH) inhibition in rats (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25788026
Corticotropin-Releasing Hormone Drives Anandamide Hydrolysis in the Amygdala to Promote Anxiety (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25740517
top
N-stearoyltyrosine protects primary cortical neurons against Aβ(1-40)-induced injury through inhibiting endocannabinoid degradation (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25637682
Further Evidence for the Neuroplastic Role of Cannabinoids: A Study in Organotypic Hippocampal Slice Cultures (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25645684
Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 suppress chronic cerebral hypoperfusion-induced neuronal apoptosis by inhibiting c-Jun N-terminal kinase signaling (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25795598
Individual differences and vulnerability to drug addiction: a focus on the endocannabinoid system (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25714966
Cannabinoid CB1 Receptor Calibrates Excitatory Synaptic Balance in the Mouse Hippocampus (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25740514
Analysis of calretinin early expression in the rat hippocampus after beta amyloid (1-42) peptide injection (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25813826
2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25814137
Localization and production of peptide endocannabinoids in the rodent CNS and adrenal medulla (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25839900
The interactive role of cannabinoid and vanilloid systems in hippocampal synaptic plasticity in rats (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25843413
Dissociation between the panicolytic effect of cannabidiol microinjected into the substantia nigra, pars reticulata, and fear-induced antinociception elicited by bicuculline administration in deep layers of the superior colliculus: The role of CB1-endoccannabinoid receptor in the ventral mesencephalon. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25841876
Emerging concepts of pain therapy based on neuronal mechanisms. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25846611
Postnatal ethanol exposure alters levels of 2-arachidonylglycerol-metabolizing enzymes and pharmacological inhibition of monoacylglycerol (MAGL) does not cause neurodegeneration in neonatal mice. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25857698
Potential of the cannabinoid CB2 receptor as a pharmacological target against inflammation in Parkinson’s disease. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25863279
Inhibition of FAAH reduces nitroglycerin-induced migraine-like pain and trigeminal neuronal hyperactivity in mice. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25910421
Enhanced function of inhibitory presynaptic cannabinoid CB1 receptors on sympathetic nerves of DOCA-salt hypertensive rats. (abst – 2015) http://www.sciencedirect.com/science/article/pii/S0024320515002155
Enhancement of endocannabinoid signalling protects against cocaine-induced neurotoxicity. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25933444
Differential Pharmacological Regulation of Sensorimotor-Gating Deficit in CB1 Knockout Mice and Associated Neurochemical and Histological Alterations (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25895455
The effect of endocannabinoid system in ischemia-reperfusion injury: a friend or a foe? (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25936364
top
Chronic ethanol exposure decreases CB1 receptor function at GABAergic synapses in the rat central amygdala. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25940135
The role of cannabinoids in adult neurogenesis. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25951750
Astroglial type-1 cannabinoid receptors (CB1): A new player in the tripartite synapse (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25967266
Layer-specific endocannabinoid-mediated LTD of GABAergic neurotransmission onto principal neurons in mouse visual cortex. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25997857
Peroxide-Dependent MGL Sulfenylation Regulates 2-AG-Mediated Endocannabinoid Signaling in Brain Neurons. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/26000748
An endocannabinoid system is present in the mouse olfactory epithelium but does not modulate olfaction. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/26037800
Involvement of cannabinoid receptors in infrasonic noise-induced neuronal impairment (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/26058582
Cannabinoid-dopamine interactions in the physiology and physiopathology of the basal ganglia (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26059564
A highly selective, reversible inhibitor identified by comparative chemoproteomics modulates diacylglycerol lipase activity in neurons (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26083464
Role of dopamine type 1 receptors and DARPP-32 in Δ9-THC-mediated induction of ΔFosB in the mouse forebrain (abst-2015) Signaling Mechanism of Cannabinoid Receptor-2 Activation-Induced β-Endorphin Release (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26108183
Colocalization of cannabinoid receptor 1 with somatostatin and neuronal nitric oxide synthase in rat brain hippocampus (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26115586
Endocannabinoid signaling mechanisms in the substantia nigra pars reticulata modulate GABAergic nigrotectal pathways in mice threatened by urutu-cruzeiro venomous pit viper snake (abst-2015) http://www.sciencedirect.com/science/article/pii/S0306452215005898
Ultrastructural evidence for synaptic contacts between cortical noradrenergic afferents and endocannabinoid-synthesizing post-synaptic neurons (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26162236
Effect of Homocysteine on Voltage-Gated Sodium Channel Currents in Primary Cultured Rat Caudate Nucleus Neurons and Its Modulation by 2-Arachidonylglycerol (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26179279
COMPARATIVE EFFECTS OF PARATHION AND CHLORPYRIFOS ON ENDOCANNABINOID AND ENDOCANNABINOID-LIKE LIPID METABOLITES IN RAT STRIATUM (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26215119
Mitochondrial CB1 receptor is involved in ACEA-induced protective effects on neurons and mitochondrial functions (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26215450
ACEA (a highly selective cannabinoid CB1 receptor agonist) stimulates hippocampal neurogenesis in mice treated with antiepileptic drugs (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26225920
Physiological roles for the subfornical organ – A dynamic transcriptome shaped by autonomic state (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26227400
Increasing levels of the endocannabinoid 2-AG is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson’s disease (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26244281
top
How The Brain Creates Marijuana-Fueled Munchies (news–2015) http://www.popsci.com/how-brain-creates-marijuana-fueled-munchies
Medical Marijuana’s Chemicals May Protect Cells (news–2015) http://www.scientificamerican.com/article/how-medical-marijuana-s-chemicals-may-protect-cells/


NEUROPATHIC PAIN

Cannabinoid-mediated modulation of neuropathic pain and microglial accumulation in a model of murine type I diabetic peripheral neuropathic pain (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2845559/?toolmcentrez
R-Flurbiprofen Reduces Neuropathic Pain in Rodents by Restoring Endogenous Cannabinoids (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2869361/
Pharmacological Treatment of Painful HIV-Associated Sensory Neuropathy: A Systematic Review and Meta-Analysis of Randomised Controlled Trials (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3010990/?toolmcentrez
Smoked cannabis for chronic neuropathic pain: a randomized controlled trial (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2950205/?toolmcentrez
Pharmacological characterization of a novel cannabinoid ligand, MDA19, for treatment of neuropathic pain (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253719/
AMELIORATIVE POTENTIAL OF CANNABIS SATIVA EXTRACT ON DIABETES INDUCED NEUROPATHIC PAIN IN RATS (full–2010) http://www.ijpsr.com/V1I11/11%20Vol%201,%20Issue%2011,%20IJPSR,%20Paper%206.pdf
Combination Of Cannabinoids For The Treatment Of Peripheral Neuropathic Pain US 2010/ 0035978 A1 Feb. 11, 2010 (full–2010) http://www.cannabisinternational.org/info/Neuropathic-Pain.pdf
Misdiagnosed chronic pelvic pain: pudendal neuralgia responding to a novel use of palmitoylethanolamide (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20345619
An Open-Label Comparison of Nabilone and Gabapentin as Adjuvant Therapy or Monotherapy in the Management of Neuropathic Pain in Patients with Peripheral Neuropathy. (abst – 2010) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=311
Effect of dronabinol on central neuropathic pain after spinal cord injury: a pilot study (abst–2010) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=313
Cannabinoid subtype-2 receptors modulate the antihyperalgesic effect of WIN 55,212-2 in rats with neuropathic spinal cord injury pain (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20920894
Study Claims Cannabis Reduces Chronic Pain (news–2010) http://www.redorbit.com/news/health/1909943/study_claims_cannabis_reduces_chronic_pain/index.html
Study: Smoking pot may ease chronic pain (news–2010) http://www.cnn.com/2010/HEALTH/08/30/health.pot.reduce.pain/
Cannabinoids inhibit and may prevent neuropathic pain in diabetes. (news – 2010) http://medigardens.blogspot.com/2010/04/march-2010-cannabinoids-inhibit-and-may.html
Study: Smoking pot may ease chronic pain (news–2010) http://www.cnn.com/2010/HEALTH/08/30/health.pot.reduce.pain/
Brief Report: Cannabidiol Prevents the Development of Cold and Mechanical Allodynia in Paclitaxel-Treated Female C57Bl6 Mice (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249239/
top
Cannabinoid Agonists Inhibit Neuropathic Pain Induced by Brachial Plexus Avulsion in Mice by Affecting Glial Cells and MAP Kinases (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3172222/?toolubmed
Self-medication of a cannabinoid CB(2) agonist in an animal model of neuropathic pain (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3157548/pdf/nihms285774.pdf
Cannabinoids for Treatment of Chronic Non-Cancer Pain; a Systematic Review of Randomized Trials (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3243008/
Mutations in ABHD12 cause the neurodegenerative disease PHARC: An inborn error of endocannabinoid metabolism (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2933347/?toolubmed
Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085542/
Activation of spinal and supraspinal cannabinoid-1 receptors leads to antinociception in a rat model of neuropathic spinal cord injury pain (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3159760/
Spinal cannabinoid CB2 receptors as a target for neuropathic pain: an investigation using chronic constriction injury (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/22210507
Cannabinoid ‘Completely’ Prevents Chemotherapy-Induced Neuropathy, Study Says (news – 2011) http://www.norml.org/index.cfm?Group_ID=8710
CBD: Marijuana Compound Has No High, But Relieves Pain (news – 2011) http://www.tokeofthetown.com/2011/10/cbd_marijuana_compound_has_no_high_but_relieves_pa.php
Marijuana component may ease pain from chemo therapy drugs (news – 2011) http://www.jpost.com/Health/Article.aspx?id=241299
Cannabidiol may help prevent paclitaxel-induced peripheral neuropathy (news – 2011) http://www.news-medical.net/news/20110926/Cannabidiol-may-help-prevent-paclitaxel-inducedperipheral-neuropathy.aspx
Prescribing Cannabis for Harm Reduction. (full – 2012) http://www.harmreductionjournal.com/content/pdf/1477-7517-9-1.pdf
The maintenance of cisplatin- and paclitaxel-induced mechanical and cold allodynia is suppressed by cannabinoid CB2 receptor activation and independent of CXCR4 signaling in models of chemotherapy-induced peripheral neuropathy (full – 2012) http://www.molecularpain.com/content/8/1/71
Therapeutic utility of palmitoylethanolamide in the treatment of neuropathic pain associated with various pathological conditions: a case series (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3500919/
Endocannabinoids in nervous system health and disease: the big picture in a nutshell (full – 2012) http://rstb.royalsocietypublishing.org/content/367/1607/3193.full
The Therapeutic Potential of Cannabis and Cannabinoids (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442177/
Dynamic changes to the endocannabinoid system in models of chronic pain (full – 2012) http://rstb.royalsocietypublishing.org/content/367/1607/3300.full?sid=1569c370-cd5c-4358-89ff-857201f5e069
Low-Dose Vaporized Cannabis Significantly Improves Neuropathic Pain. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3566631/
Modulation of neuropathic-pain-related behaviour by the spinal endocannabinoid/endovanilloid system (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3481534/
Prevention of Paclitaxel-Induced Neuropathy Through Activation of the Central Cannabinoid Type 2 Receptor System (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334436/
top
The Novel Reversible Fatty Acid Amide Hydrolase Inhibitor ST4070 Increases Endocannabinoid Brain Levels and Counteracts Neuropathic Pain in Different Animal Models (full – 2012) http://jpet.aspetjournals.org/content/342/1/188.full.pdf+html
Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3371734/
Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525790/
The atypical cannabinoid O-1602 increases hind paw sensitisation in the chronic constriction injury model of neuropathic pain (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22227298
Cannabinoid agonist WIN 55,212-2 prevents the development of paclitaxel-induced peripheral neuropathy in rats. Possible involvement of spinal glial cells (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22374260
Low brain penetrant CB1 receptor agonists for the treatment of neuropathic pain. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22421020
Characterization of cannabinoid-induced relief of neuropathic pain in rat models of type 1 and type 2 diabetes. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22609797
A Randomized, Double-Blind, Placebo Controlled, Parallel Assignment, Flexible Dose, Efficacy Study of Nabilone as Adjuvant in the Treatment of Diabetic Peripheral Neuropathic Pain Using an Enriched Enrollment Randomized Withdrawal Design (S38.003) (abst–2012) http://www.neurology.org/cgi/content/meeting_abstract/78/1_MeetingAbstracts/S38.003?maxtoshow=&hits=25&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=180&sortspec=date&resourcetype=HWCIT
An enriched-enrolment, randomized withdrawal, flexible-dose, double-blind, placebocontrolled, parallel assignment efficacy study of nabilone as adjuvant in the treatment of diabetic peripheral neuropathic pain (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22921260
Peripheral antinociceptive effect of anandamide and drugs that affect the endocannabinoid system on the formalin test in normal and streptozotocin-diabetic rats (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22959964
A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23180178
Palmitoylethanolamide is a new possible pharmacological treatment for the inflammation associated with trauma (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22697514?dopt=Abstract
Multimodal stepped care approach with acupuncture and PPAR-α agonist palmitoylethanolamide in the treatment of a patient with multiple sclerosis and central neuropathic pain (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22301508
California pot research backs therapeutic claims (news–2012) http://www.sacbee.com/2012/07/12/4625608/california-pot-research-backs.html
Cannabis as Painkiller (news–2012) http://www.sciencedaily.com/releases/2012/08/120807101232.htm
Study: Synthetic THC Analogue Mitigates Diabetic Neuropathy, Is ‘Well Tolerated’ In Patients (news – 2012) http://norml.org/news/2012/09/20/study-synthetic-thc-analogue-mitigates-diabetic-neuropathy-is-welltolerated-in-patients
New drug offers novel pain management therapy for diabetics (news–2012) http://www.thefreelibrary.com/New+drug+offers+novel+pain+management+therapy+for+diabetics.-a0306899453
Synthetic cannabinoid could treat pain in diabetes patients (news–2012) http://www.medwirenews.com/57/102248/Diabetes/Synthetic_cannabinoid_could_treat_pain_in_diabetes_patients_.html
top
Drug offers new pain management therapy for diabetics (news–2012) http://medicalxpress.com/news/2012-10-drug-pain-therapy-diabetics.html
The role of endocannabinoids in pain modulation (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/fcp.12008/pdf
The Major Brain Endocannabinoid 2-AG Controls Neuropathic Pain and Mechanical Hyperalgesia in Patients with Neuromyelitis Optica. (full – 2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0071500
Drug Design for Neuropathic Pain Regulation from Traditional Chinese Medicine. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3558695/
Full Inhibition of Spinal FAAH Leads to TRPV1-Mediated Analgesic Effects in Neuropathic Rats and Possible Lipoxygenase-Mediated Remodeling of Anandamide Metabolism (full – 2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0060040
The cannabinoid CB2 receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain (full – 2013) http://www.europeanneuropsychopharmacology.com/article/S0924-977X%2813%2900302-7/fulltext
The endocannabinoid system, cannabinoids, and pain (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820295/
Therapeutic potential of cannabinoid medicines. (full – 2013) http://onlinelibrary.wiley.com/doi/10.1002/dta.1529/full
Non-Neuronal Cell Modulation Relieves Neuropathic Pain: Efficacy of the Endogenous Lipid Palmitoylethanolamide (link to PDF – 2013) http://www.eurekaselect.com/107974/article
Palmitoylethanolamide Reduces Formalin-Induced Neuropathic-Like Behaviour Through Spinal Glial/Microglial Phenotypical Changes in Mice (link to PDF – 2013) http://www.eurekaselect.com/107975/article
Different Classes of CB2 Ligands Potentially Useful in the Treatment of Pain (link to PDF – 2013) http://www.eurekaselect.com/108399/article
Medicinal Cannabis and Painful Sensory Neuropathy (editorial – 2013) http://virtualmentor.ama-assn.org/2013/05/oped1-1305.html
Characterisation of cannabinoid-induced relief of neuropathic pain in a rat model of cisplatin-induced neuropathy. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23454533
Anandamide deficiency and heightened neuropathic pain in aged mice. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23597506
A Double-Blind, Placebo-Controlled, Crossover Pilot Trial With Extension Using an Oral Mucosal Cannabinoid Extract for Treatment of Chemotherapy-Induced Neuropathic Pain. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23742737
Palmitoylethanolamide is a New Possible Pharmacological Treatment for the Inflammation Associated with Trauma (abst – 2013) http://www.eurekaselect.com/106175/article
Activation of spinal cannabinoid cb2 receptors inhibits neuropathic pain in streptozotocin-induced diabetic mice. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23892011
Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT1A receptors without diminishing nervous system function or chemotherapy efficacy. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24117398
Endocannabinoids decrease neuropathic pain-related behavior in mice through the activation of one or both peripheral CB1 and CB2 receptors. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24148808
Is Marijuana Medicinal? (news–2013) http://www.rheumatologynews.com/index.php?id=8821&cHash=071010&tx_ttnews%5Btt_news%5D=127219
Study: Vaporized, Low-Potency Cannabis Mitigates Neuropathic Pain (news–2013) http://blog.norml.org/2013/01/03/study-vaporized-low-potency-cannabis-mitigates-neuropathic-pain/
Prophylactic cannabinoid administration blocks the development of paclitaxel-induced neuropathic nociception during analgesic treatment and following cessation of drug delivery (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998744/
top
Therapeutic benefits of cannabis: a patient survey (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998228/
Celastrol Attenuates Inflammatory and Neuropathic Pain Mediated by Cannabinoid Receptor Type 2 (link to PDF–2014) http://www.mdpi.com/1422-0067/15/8/13637
A double-blind, randomized, placebo-controlled, parallel group study of THC/CBD spray in peripheral neuropathic pain treatment (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24420962
Endocannabinoids and neuropathic pain: focus on neuron-glia and endocannabinoidneurotrophin interactions (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24494680
Involvement of the endocannabinoid system in osteoarthritis pain (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24494687
Hemopressin, an inverse agonist of cannabinoid receptors, inhibits neuropathic pain in rats (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24703998
Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24836296
Augmented tonic pain-related behavior in knockout mice lacking monoacylglycerol lipase, a major degrading enzyme for the endocannabinoid 2-arachidonoylglycerol (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24906199
(Mo1122) Prevalence and Characterization of Cannabinoid Use in Patients With Gastrointestinal Disorders (abst-2014) http://www.gastrojournal.org/article/S0016-5085%2814%2962037-0/pdf
Combined inhibition of FAAH and COX produces enhanced anti-allodynic effects in mouse neuropathic and inflammatory pain models (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25058512
Cannabinoids for Neuropathic Pain (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25160710
Neuropathic orofacial pain: Cannabinoids as a therapeutic avenue (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25150831
The Pharmacokinetics, Efficacy, Safety, and Ease of Use of a Novel Portable Metered Dose Cannabis Inhaler in Patients With Chronic Neuropathic Pain: A Phase 1a Study (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25118789
JZL184 is anti-hyperalgesic in a murine model of cisplatin-induced peripheral neuropathy (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25304184
There is evidence for the use of cannabinoids for symptomatic treatment of multiple sclerosis (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25350886
Dual inhibition of monoacylglycerol lipase and cyclooxygenases synergistically reduces neuropathic pain in mice (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25393148
Attenuation of persistent pain-related behavior by fatty acid amide hydrolase (FAAH) inhibitors in a rat model of HIV sensory neuropathy (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25486617
Effects of repeated dosing with mechanistically distinct antinociceptive ligands in a rat model of neuropathic spinal cord injury pain (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25505583
Discriminating the effects of Cannabis sativa and Cannabis indica: a web survey of medical cannabis users (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25191852
top
Inhibition of anandamide hydrolysis attenuates nociceptor sensitization in a murine model of chemotherapy-induced peripheral neuropathy (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25505113
Study: Cannabis Inhaler Delivers Effective Relief To Neuropathy Patients (news-2014) http://blog.norml.org/2014/08/18/study-cannabis-inhaler-delivers-effective-relief-to-neuropathy-patients/
The spinal anti-inflammatory mechanism of motor cortex stimulation: cause of success and refractoriness in neuropathic pain? (full-2015) http://www.jneuroinflammation.com/content/pdf/s12974-014-0216-1.pdf
Nabilone as an Adjunctive to Gabapentin for Multiple Sclerosis-Induced Neuropathic Pain: A Randomized Controlled Trial (full-2015) http://onlinelibrary.wiley.com/doi/10.1111/pme.12569/full
Combined inhibition of monoacylglycerol lipase and cyclooxygenases synergistically reduces neuropathic pain in mice (abst-2015) http://onlinelibrary.wiley.com/doi/10.1111/bph.13012/abstract
The Effectiveness of Cannabinoids in the Management of Chronic Nonmalignant Neuropathic Pain: A Systematic Review (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25635955
The spinal anti-inflammatory mechanism of motor cortex stimulation: cause of success and refractoriness in neuropathic pain? (full-2015) http://www.jneuroinflammation.com/content/pdf/s12974-014-0216-1.pdf
Nabilone as an Adjunctive to Gabapentin for Multiple Sclerosis-Induced Neuropathic Pain: A Randomized Controlled Trial (full-2015) http://onlinelibrary.wiley.com/doi/10.1111/pme.12569/full
Tonic Modulation of Nociceptive Behavior and Allodynia by Cannabinoid Receptors in Formalin Test in Rats (full-2015) http://www.cps.org.tw/files/201503160252300.pdf
Cannabis in cancer care (full–2015) http://onlinelibrary.wiley.com/doi/10.1002/cpt.108/full
Coadministration of indomethacin and minocycline attenuates established paclitaxelinduced neuropathic thermal hyperalgesia: Involvement of cannabinoid CB1 receptors (full–2015) http://www.nature.com/srep/2015/150618/srep10541/pdf/srep10541.pdf
Medical marijuana: Hints of headway? Despite a conflicted regulatory landscape, support for medical marijuana is growing amid increasing evidence of potential benefits (Part 2 of 2) (article-2015) http://onlinelibrary.wiley.com/doi/10.1002/cncy.21524/full
The entourage effect: Synergistic actions of plant cannabinoids (letter-2015) http://www.researchgate.net/publication/273330402_The_entourage_effect_Synergistic_actions_of_plant_cannabinoids
Combined inhibition of monoacylglycerol lipase and cyclooxygenases synergistically reduces neuropathic pain in mice (abst-2015) http://onlinelibrary.wiley.com/doi/10.1111/bph.13012/abstract
The Effectiveness of Cannabinoids in the Management of Chronic Nonmalignant Neuropathic Pain: A Systematic Review (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25635955
Influence of nitric oxide synthase or cyclooxygenase inhibitors on cannabinoids activity in streptozotocin-induced neuropathy (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25712641
Efficacy of Inhaled Cannabis on Painful Diabetic Neuropathy (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25843054
CB1 receptors modulate affective behaviour induced by neuropathic pain (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25863168
CB1 Knockout Mice Unveil Sustained CB2-Mediated Anti-Allodynic Effects of the Mixed CB1/CB2 Agonist CP55,940 in a Mouse Model of Paclitaxel-Induced Neuropathic Pain (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25904556
top
A Cannabinoid CB1 Receptor Positive Allosteric Modulator Reduces Neuropathic Pain in the Mouse with no Psychoactive Effects (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26052038
N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of Resolution (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26055231
Minimizing chemotherapy-induced peripheral neuropathy: preclinical and clinical development of new perspectives (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26058312
Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems: A Clinical Review (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26103031
When Weed Is The Cure: A Doctor’s Case for Medical Marijuana (interview-2015) http://www.npr.org/sections/health-shots/2015/07/14/422876973/when-weed-is-the-cure-a-doctors-casefor-medical-marijuana?utm_medium=RSS&utm_campaign=authorinterviews
Cannabis Salve for Pain- Neuropathy – Yep, I had shingles. 😦 (news-2015) http://www.hempista.com/2015/cannabis-salve-pain-neuropathy-shingles/
Cannabis alleviates peripheral neuropathic pain in diabetes (news-2015) http://medicalxpress.com/news/2015-07-cannabis-alleviates-peripheral-neuropathic-pain.html


NEUROPROTECTION
Neuroprotective potential of CB1 receptor agonists in an in vitro model of Huntington’s disease (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931573/?toolubmed
Learning and memory performances in adolescent users of alcohol and marijuana: interactive effects (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2965487/
The effects of Delta-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931570/?toolubmed
The Neuroprotective Effect of Cannabinoid Receptor Agonist (WIN55,212-2) in Paraoxon Induced Neurotoxicity in PC12 Cells and N-methyl-D-aspartate Receptor Interaction (full-2010) http://celljournal.org/library/upload/article/af_4334422Hashemi.pdf
THC Prevents MDMA Neurotoxicity in Mice (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2824821/
The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxicischemic brain damage in mice is mediated by CB(2) and adenosine receptors (abst-2010) http://www.ncbi.nlm.nih.gov/pubmed/19900555
Cannabinoid receptor agonist protects cultured dopaminergic neurons from the death by the proteasomal dysfunction (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3145842/?toolubmed
Inhibition of COX-2 expression by endocannabinoid 2-arachidonoylglycerol is mediated via PPAR-γ (full-2011) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2011.01444.x/full
N-arachidonoyl–serine is neuroprotective after traumatic brain injury by reducing apoptosis (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3170948/
Cannabinoid Receptor Type 1 Protects Nigrostriatal Dopaminergic Neurons against MPTP Neurotoxicity by Inhibiting Microglial Activation (full-2011) http://www.jimmunol.org/content/187/12/6508.full?sid=c3422dd2-7ad0-42e4-a862-845dc670f7cf
top
Pharmacological activation/inhibition of the cannabinoid system affects alcohol withdrawal-induced neuronal hypersensitivity to excitotoxic insults (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3158793/
HIV-1 infection and alcohol abuse: neurocognitive impairment, mechanisms of neurodegeneration and therapeutic interventions (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3098312/
Endocannabinoid 2-arachidonoylglycerol protects neurons against β-amyloid insults (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3052737/pdf/nihms266962.pdf
Cannabinoid-containing plant extracts as neuroprotective agents – Patent EP2332533 (A1) – 2011-06-15 (full-2011) http://worldwide.espacenet.com/publicationDetails/description?CC=EP&NR=2332533A1&KC=A1&FT&ND=3&date=20110615&DB=EPODOC&locale=en_EP
Cannabinoids and Innate Immunity: Taking a Toll on Neuroinflammation (link to PDF–2011) http://www.tswj.com/2011/230786/abs/
Overexpression of CB2 cannabinoid receptors results in neuroprotection against behavioral and neurochemical alterations induced by intracaudate administration of 6-hydroxydopamine. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/20980074
Immunomodulatory properties of kappa opioids and synthetic cannabinoids in HIV-1 neuropathogenesis (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21850403
New metabolic pathway for controlling brain inflammation (news–2011) http://www.news-medical.net/news/20111021/New-metabolic-pathway-for-controlling-braininflammation.aspx
Update on the role of cannabinoid receptors after ischemic stroke (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3337695/?toolubmed
Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-α (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3315437/?toolubmed
Dimerization with Cannabinoid Receptors Allosterically Modulates Delta Opioid Receptor Activity during Neuropathic Pain (full–2012) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0049789
Contribution of Hypothermia and CB(1) Receptor Activation to Protective Effects of TAK-937, a Cannabinoid Receptor Agonist, in Rat Transient MCAO Model (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3397930/?toolubmed
Early Endogenous Activation of CB1 and CB2 Receptors after Spinal Cord Injury Is a Protective Response Involved in Spontaneous Recovery (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496738/
Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-α (full–2012) http://www.jneuroinflammation.com/content/9/1/49
Endocannabinoids in nervous system health and disease: the big picture in a nutshell (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3193.full
Intrinsic Up-Regulation of 2-AG Favors an Area Specific Neuronal Survival in Different In Vitro Models of Neuronal Damage (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3527460/
Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid? (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579248/
Review article: The endocannabinoid system in normal and pathological brain ageing (full-2012) http://rstb.royalsocietypublishing.org/content/367/1607/3326.full?sid=161e7b36-5055-448b-962e-697c782e901d
top
Sativex-like Combination of Phytocannabinoids is Neuroprotective in Malonate-Lesioned Rats, an Inflammatory Model of Huntington’s Disease: Role of CB(1) and CB(2) Receptors (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382456/
Prevention of Paclitaxel-Induced Neuropathy Through Activation of the Central Cannabinoid Type 2 Receptor System (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334436/
Cannabinoid type 2 receptor activation downregulates stroke-induced classic and alternative brain macrophage/microglial activation concomitant to neuroprotection (full-2012) http://stroke.ahajournals.org/content/43/1/211.long
CB1 Agonist ACEA Protects Neurons and Reduces the Cognitive Impairment of AβPP/PS1 Mice (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22451318
CB1 cannabinoid receptor activation rescues amyloid β-induced alterations in behaviour and intrinsic electrophysiological properties of rat hippocampal CA1 pyramidal neurones (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22508047
Anandamide and 2-arachidonoylglycerol: Pharmacological Properties, Functional Features, and Emerging Specificities of the Two Major Endocannabinoids (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22801993
Overexpression of CB2 cannabinoid receptors results in neuroprotection against behavioral and neurochemical alterations induced by intracaudate administration of 6-hydroxydopamine (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/20980074
Δ(9)-THC exerts a direct neuroprotective effect in a human cell culture model of Parkinson’s disease (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22236282
Single-dose Pharmacokinetics and Tolerability of Oral Delta-9-Tetrahydrocannabinol in Patients with Amyotrophic Lateral Sclerosis (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22594565
Effects of cannabinoids Δ(9)-tetrahydrocannabinol, Δ(9)-tetrahydrocannabinolic acid and cannabidiol in MPP(+) affected murine mesencephalic cultures (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22571976
A cannabinoid type 2 receptor agonist attenuates blood-brain barrier damage and neurodegeneration in a murine model of traumatic brain injury (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22903455
A Cannabigerol Quinone Alleviates Neuroinflammation in a Chronic Model of Multiple Sclerosis (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22971837
Cannabinoid Receptor Subtypes 1 and 2 Mediate Long-Lasting Neuroprotection and Improve Motor Behaviour Deficits After Transient Focal Cerebral Ischemia. (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/23069763
WIN55,212-2 protects oligodendrocyte precursor cells in stroke penumbra following permanent focal cerebral ischemia in rats (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/23202804
WIN55, 212-2 promotes differentiation of oligodendrocyte precursor cells and improve remyelination through regulation of the phosphorylation level of the ERK 1/2 via cannabinoid receptor 1 after stroke-induced demyelination (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/23202804
Palmitoylethanolamide is a new possible pharmacological treatment for the inflammation associated with trauma (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22697514?dopt=Abstract
Specific inhibition of the JNK pathway promotes locomotor recovery and neuroprotection after mouse spinal cord injury (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22426389
Long-term behavioral and biochemical effects of an ultra-low dose of Δ(9)-tetrahydrocannabinol (THC): neuroprotection and ERK signaling (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22821081
top
Researchers study neuroprotective properties in cannabis (news-2012) http://www.foxnews.com/health/2012/03/20/researchers-study-neuroprotective-properties-in-cannabis/
Cannabinoids May Help Prevent MDMA induced brain damage (news-2012) http://www.examiner.com/article/cannabinoids-may-help-prevent-mdma-induced-brain-damage
Molecular evidence for the involvement of PPAR-δ and PPAR-γ in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma (full-2013) http://www.jneuroinflammation.com/content/10/1/20
Neuroprotective effects of Cannabis sativa leaves extracts on α-Motoneurons density after sciatic nerve injury in rats (full-2013) http://www.lifesciencesite.com/lsj/life1005s/113_15973life1005s_644_648.pdf
HINT1 protein cooperates with cannabinoid 1 receptor to negatively regulate glutamate NMDA receptor activity (full-2013) http://www.molecularbrain.com/content/6/1/42
CB2 Receptor Agonists Protect Human Dopaminergic Neurons against Damage from HIV-1 gp120 (full-2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0077577
Molecular targets underlying SUMO-mediated neuroprotection in brain ischemia (full-2013) http://onlinelibrary.wiley.com/doi/10.1111/jnc.12347/full
A new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injury (full-2013) http://www.jneuroinflammation.com/content/10/1/91
Selective inhibition of alpha/beta-hydrolase domain 6 attenuates neurodegeneration, alleviates blood brain barrier breakdown, and improves functional recovery in a mouse model of traumatic brain injury (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3636589/
The Influence of Cannabinoids on Generic Traits of Neurodegeneration (full-2013) http://onlinelibrary.wiley.com/doi/10.1111/bph.12492/full
Does the neuroprotective role of anandamide display diurnal variations? (link to PDF-2013) http://www.mdpi.com/1422-0067/14/12/23341
Palmitoylethanolamide in Homeostatic and Traumatic Central Nervous System Injuries (link to PDF-2013) http://www.eurekaselect.com/107976/article
Neuroglial Roots of Neurodegenerative Diseases: Therapeutic Potential of Palmitoylethanolamide in Models of Alzheimer’s Disease (link to PDF-2013) http://www.eurekaselect.com/107977/article
Activation of the CB(2) receptor system reverses amyloid-induced memory deficiency (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/22795792
Nicotine-Induced Neuroprotection Against Ischemic Injury Involves Activation of Endocannabinoid System in Rats (abst-2013) http://link.springer.com/article/10.1007/s11064-012-0927-6
The neuroprotective role of endocannabinoids against chemical-induced injury and other adverse effects (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/23296873
Neuroprotective effects of topical CB1 agonist WIN 55212-2 on Retinal ganglion cells after acute rise in intraocular pressure induced ischemia in rat. (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/23454099
Mechanisms Of Cannabidiol Neuroprotection In Hypoxic-Ischemic Newborn Pigs: Role Of 5HT1A And CB2 Receptors (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/23587650
Glia and Mast Cells as Targets for Palmitoylethanolamide, an Anti-inflammatory and Neuroprotective Lipid Mediator (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/23813098
top
CB1 and CB2 Cannabinoid Receptor Antagonists Prevent Minocycline-Induced Neuroprotection Following Traumatic Brain Injury in Mice (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/23960212
Neuroprotection and reduction of glial reaction by cannabidiol treatment after sciatic nerve transection in neonatal rats (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/23981015
Cannabinoid Effects on β Amyloid Fibril and Aggregate Formation, Neuronal and Microglial-Activated Neurotoxicity In Vitro (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/24030360
Activation of STAT3 is involved in neuroprotection by electroacupuncture pretreatment via cannabinoid CB1 receptors in rats (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/23880371
Δ9-Tetrahydrocannabinol is protective through PPARγ dependent mitochondrial biogenesis in a cell culture model of Parkinson’s Disease (abst-2013) http://jnnp.bmj.com/content/84/11/e2.58.abstract
CB2 cannabinoid agonist enhanced neurogenesis in GFAP/Gp120 transgenic mice displaying deficits in neurogenesis (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/24148086
Transdermal delivery of cannabidiol attenuates binge alcohol-induced neurodegeneration in a rodent model of an alcohol use disorder (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/24012796
Cannabidiol Normalizes Capase 3, Synatophsin, and Mitochondrial Fission Protein DNM1L Expression Levels in Rats with Brain Iron Overload: Implications for Neuroprotection (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/23893294
Neuroimmmune interactions of cannabinoids in neurogenesis: focus on interleukin-1β (IL-1β signalling (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/24256257
Cannabidiol Promotes Amyloid Precursor Protein Ubiquitination and Reduction of Beta Amyloid Expression in SHSY5YAPP+ Cells Through PPARγ Involvement (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/24288245
Low Doses of THC (Cannabis) Can Halt Brain Damage, Study Suggests (news-2013) http://www.sciencedaily.com/releases/2013/05/130530132531.htm
Activation of cortical type 2 cannabinoid receptors ameliorates ischemic brain injury (news-2013) http://www.sciencedaily.com/releases/2013/02/130221141140.htm
Chemicals in marijuana ‘protect nervous system’ against MS (news-2013) http://www.medicalnewstoday.com/articles/267161.php

Δ9-tetrahydrocannabinol prevents methamphetamine-induced neurotoxicity (full-2014) http://www.plosone.org/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0098079&representationDF
The endocannabinoid system: a putative role in neurodegenerative diseases (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4070159/
A restricted population of CB1 cannabinoid receptors with neuroprotective activity (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4050577/
Cannabinoids: well-suited candidates for the treatment of perinatal brain injury (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4061885/
Regulatory role of the Cannabinoid-2 receptor in stress-induced neuroinflammation in mice (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24467609
top
Trans-Caryophyllene Suppresses Hypoxia-Induced Neuroinflammatory Responses by Inhibiting NF-κB Activation in Microglia (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24488604
Neuroprotective effects of the cannabinoid agonist HU210 on retinal degeneration (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24495949
Endocannabinoid 2-Arachidonylglycerol Protects Primary Cultured Neurons Against LPS-Induced Impairments in Rat Caudate Nucleus (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24510751
Endocannabinoids in Synaptic Plasticity and Neuroprotection (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24571856
Prior stimulation of the endocannabinoid system prevents methamphetamine-induced dopaminergic neurotoxicity in the striatum through activation of CB2 receptors (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24709540
Changes in Endocannabinoid Receptors and Enzymes in the Spinal Cord of SOD1G93A Transgenic Mice and Evaluation of a Sativex® -like Combination of Phytocannabinoids: Interest for Future Therapies in Amyotrophic Lateral Sclerosis (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24703394
Effect of N-Arachidonoyl Dopamine on Activity of Neuronal Network in Primary Hippocampus Culture upon Hypoxia Modelling (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24771427
Functions of the CB1 and CB 2 Receptors in Neuroprotection at the Level of the Blood-Brain Barrier (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24929655
The fatty acid amide hydrolase inhibitor PF-3845 promotes neuronal survival, attenuates inflammation and improves functional recovery in mice with traumatic brain injury (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24937045
The monoacylglycerol lipase inhibitor JZL184 is neuroprotective and alters glial cell phenotype in the chronic MPTP mouse model (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24973119
Cannabinoid receptor activation inhibits cell cycle progression by modulating 14-3-3β (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25002257
Endocannabinoid 2-Arachidonylglycerol Protects Primary Cultured Neurons Against Homocysteine-Induced Impairments in Rat Caudate Nucleus Through CB1 Receptor (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25007951
Cannabinoid Receptor-2 and HIV-Associated Neurocognitive Disorders (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25015040
Ultralow doses of cannabinoid drugs protect the mouse brain from inflammation-induced cognitive damage (abst-2014) http://onlinelibrary.wiley.com/doi/10.1002/jnr.23452/abstract
Chronic cannabinoid receptor stimulation selectively prevents motor impairments in a mouse model of Huntington’s disease (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25123645
Distinct modulation of the endocannabinoid system upon kainic acid-induced in vivo seizures and in vitro epileptiform bursting (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25064144
Neuroprotection by association of palmitoylethanolamide with luteolin in experimental Alzheimer’s disease models: the control of neuroinflammation (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25106636
Impaired Neurogenesis by HIV-1-Gp120 is Rescued by genetic deletion of Fatty Acid Amide Hydrolase Enzyme (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24571443
Rising stars: Modulation of brain functions by astroglial type-1 cannabinoid receptors (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25452006
Neuroprotection in Experimental Autoimmune Encephalomyelitis and Progressive Multiple Sclerosis by Cannabis-Based Cannabinoids (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25537576
top
Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1∆E9 mice (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24577515
On the Role of Astroglial Syncytia in Self-Repairing Spiking Neural Networks (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25576582
Cannabidiol increases survival and promotes rescue of cognitive function in a murine model of Cerebral Malaria (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25595981
N-stearoyltyrosine protects primary cortical neurons against Aβ(1-40)-induced injury through inhibiting endocannabinoid degradation (abst-2015) http://www.sciencedirect.com/science/article/pii/S0024320515000521
Endocannabinoid degradation inhibition improves neurobehavioral function, blood brain barrier integrity, and neuroinflammation following mild traumatic brain injury (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25166905
Cannabinoid-mediated short-term plasticity in hippocampus (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25123173
Neuroprotective Properties of Cannabigerol in Huntington’s Disease: Studies in R6/2 Mice and 3-Nitropropionate-lesioned Mice (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25252936
Mn-SOD Upregulation by Electroacupuncture Attenuates Ischemic Oxidative Damage via CB1R-Mediated STAT3 Phosphorylation (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25432886
Magnolol protects neurons against ischemia injury via the downregulation of p38/MAPK, CHOP and nitrotyrosine (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25038313
Normal aging in rats and pathological aging in human Alzheimer disease decrease FAAH activity: Modulation by cannabinoid agonists (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25456842
Palmitoylethanolamide controls reactive gliosis and exerts neuroprotective functions in a rat model of Alzheimer’s disease (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25210802
Neuroprotection by association of palmitoylethanolamide with luteolin in experimental Alzheimer’s disease models: the control of neuroinflammation (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25106636
Impaired Neurogenesis by HIV-1-Gp120 is Rescued by genetic deletion of Fatty Acid Amide Hydrolase Enzyme (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24571443
Rising stars: Modulation of brain functions by astroglial type-1 cannabinoid receptors (abst-2014)http://www.ncbi.nlm.nih.gov/pubmed/25452006
Neuroprotection in Experimental Autoimmune Encephalomyelitis and Progressive Multiple Sclerosis by Cannabis-Based Cannabinoids (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25537576
Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1∆E9 mice (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24577515
On the Role of Astroglial Syncytia in Self-Repairing Spiking Neural Networks (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25576582
Cannabidiol increases survival and promotes rescue of cognitive function in a murine model of Cerebral Malaria (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25595981
N-stearoyltyrosine protects primary cortical neurons against Aβ(1-40)-induced injury through inhibiting endocannabinoid degradation (abst-2015) http://www.sciencedirect.com/science/article/pii/S0024320515000521
Effects of pro-inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cells (full-2015) http://onlinelibrary.wiley.com/doi/10.1111/apha.12474/full
top
The CB1 cannabinoid receptor signals striatal neuroprotection via a PI3K/Akt/mTORC1/BDNF pathway (full-2015) http://www.nature.com/cdd/journal/vaop/ncurrent/full/cdd201511a.html
Palmitoylethanolamide Inhibits Glutamate Release in Rat Cerebrocortical Nerve Terminals (full-2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4394492/
Palmitoyl Serine: An Endogenous Neuroprotective Endocannabinoid-Like Entity After Traumatic Brain Injury (full-2015) http://tinyurl.com/oj2y33t
On the Role of Astroglial Syncytia in Self-Repairing Spiking Neural Networks (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25576582
Cannabidiol increases survival and promotes rescue of cognitive function in a murine model of Cerebral Malaria (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25595981
N-stearoyltyrosine protects primary cortical neurons against Aβ(1-40)-induced injury through inhibiting endocannabinoid degradation (abst-2015) http://www.sciencedirect.com/science/article/pii/S0024320515000521
The therapeutic potential of cannabinoids for movement disorders (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25649017
Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 suppress chronic cerebral hypoperfusion-induced neuronal apoptosis by inhibiting c-Jun N-terminal kinase signaling (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25795598
Elevation of Plasma 2-Arachidonoylglycerol Levels in Alzheimer’s Disease Patients as a Potential Protective Mechanism against Neurodegenerative Decline. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25818503
Monoacylglycerol Lipase Inhibitor Protects Primary Cultured Neurons Against Homocysteine-induced Impairments in Rat Caudate Nucleus through COX-2 signaling (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25818189
Protective effect of paeoniflorin on the hippocampus in rats with cerebral ischemiareperfusion through activating cannabinoid receptor 2 (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25854559
A sativex-like combination of phytocannabinoids as a disease-modifying therapy in a viral model of multiple sclerosis (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25857324
Potential of the cannabinoid CB2 receptor as a pharmacological target against inflammation in Parkinson’s disease (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25863279
Endocannabinoids regulate the activity of astrocytic hemichannels and the microglial response against an injury: In vivo studies (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25917763
Enhancement of endocannabinoid signalling protects against cocaine-induced neurotoxicity (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25933444
The effect of endocannabinoid system in ischemia-reperfusion injury: a friend or a foe? (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25936364
Cannabinoid receptor 2 attenuates microglial accumulation and brain injury following germinal matrix hemorrhage via ERK dephosphorylation in vivo and in vitro (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25963415
Neuroprotective Effect of JZL184 in MPP+-Treated SH-SY5Y Cells Through CB 2 Receptors (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25976369
Synthetic and endogenous cannabinoids protect retinal neurons from AMPA excitotoxicity in vivo, via activation of CB1 receptors: Involvement of PI3K/Akt and MEK/ERK signaling pathways (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25989217
top
N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of Resolution (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26055231
Combined neuroprotective action of adenosine A1 and cannabinoid CB1 receptors against NMDA-induced excitotoxicity in the hippocampus (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26065937
Effect of Homocysteine on Voltage-Gated Sodium Channel Currents in Primary Cultured Rat Caudate Nucleus Neurons and Its Modulation by 2-Arachidonylglycerol (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26179279
Mitochondrial CB1 receptor is involved in ACEA-induced protective effects on neurons and mitochondrial functions (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26215450
Endogenous 2-Arachidonoylglycerol Alleviates Cyclooxygenases-2 Elevation-Mediated Neuronal Injury from SO2 Inhalation via PPARγ Pathway (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26209559
Increasing levels of the endocannabinoid 2-AG is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson’s disease (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26244281
Is it time to legalize marijuana in sports? (news-2015) http://www.sandiegouniontribune.com/news/2015/aug/01/marijuana-sports-opioids-arguments-kyle-turley/


NUTRITION-GENERAL
Exposure to a high-fat diet decreases sensitivity to Δ9-tetrahydrocannabinol-induced motor effects in female rats (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3014410/
Scientists Find New Sources of Plant Cannabinoids Other than Medical Marijuana? (news-2010) http://montanabiotech.wordpress.com/2011/03/26/scientists-find-new-sources-of-plant-cannabinoids-otherthan-medical-marijuana/
Cannabis as a Unique Functional Food (full-2011) http://apothecary-genetics.spruz.com/gfile/75r4!-!HLKELE!-!svyr5/cannabis_as_a_unique_functional_food.pdf
Poor Diet Impairs Cannabinoid Receptors (news-2011) http://www.freedomisgreen.com/poor-diet-impairs-cannabinoid-receptors/
Hemp Food Storage (article-2012) http://www.innvista.com/health/foods/hemp/hemp-food-storage/
Changes on metabolic parameters induced by acute cannabinoid administration (CBD, THC) in a rat experimental model of nutritional vitamin A deficiency (full-2013) http://www.nutricionhospitalaria.com/pdf/6430.pdf
Mangoes Elevate High From Smoking Marijuana: Are They A Healthier Alternative To The ‘Munchies’? (news-2013) http://www.medicaldaily.com/mangoes-elevate-high-smoking-marijuana-are-they-healthier-alternativemunchies-247892
Endocannabinoid signaling and its regulation by nutrients (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24753395
Developmentally vitamin D-deficient rats show enhanced prepulse inhibition after acute Δ9-tetrahydrocannabinol (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24776491
How to Stay Healthy While You’re High (news-2015) http://tinyurl.com/nqpmrou
top


NUTRITION-HEMP SEED
The cardiac and haemostatic effects of dietary hempseed (full–2010) http://www.nutritionandmetabolism.com/content/pdf/1743-7075-7-32.pdf
Influence of Feed Supplementation with Cannabis Sativa on Quality of Broilers Carcass (full-2010) http://www.pvj.com.pk/pdf-files/30_1/34-38.pdf
Information on Chia, Hemp & Flax (article–2010) http://www.ehow.com/facts_7460031_information-chia_-hemp-flax.html
Dietary intakes in a group of marihuana smoking patients (abst-2010) http://www.ncbi.nlm.nih.gov/pubmed/20694309
Evaluating the Quality of Protein from Hemp Seed (Cannabis sativa L) Products Through the use of the Protein Digestibility-Corrected Amino Acid Score Method (abst-2010) http://pubs.acs.org/doi/abs/10.1021/jf102636b
The Calories in Hemp Seeds (news-2010) http://www.livestrong.com/article/317603-the-calories-in-hemp-seeds/
Hemp Seeds are Full of Health (news-2010) http://www.naturalnews.com/029729_hemp_seeds_health.html
Unhulled Hemp Seed Uses (news-2010) http://www.livestrong.com/article/212391-unhulled-hemp-seed-uses/
What Is Hemp Protein? (news-2010) http://www.livestrong.com/article/99020-hemprotein/
Efficacy of a Chinese herbal proprietary medicine (Hemp Seed Pill) for functional constipation (full-2011) http://www.nature.com/ajg/journal/v106/n1/pdf/ajg2010305a.pdf
The effects of hempseed meal intake and linoleic acid on Drosophila models of neurodegenerative diseases and hypercholesterolemia (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3933972/
The effect of dietary hempseed on atherogenesis and contractile function in aortae from hypercholesterolemic rabbits (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21893466
Distinctive effects of plant protein sources on renal disease progression and associated cardiac hypertrophy in experimental kidney disease (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21294251
What Are the Benefits of Hemp Seeds for Toddlers? (news-2011) http://www.livestrong.com/article/519202-what-are-the-benefits-of-hemp-seeds-fortoddlers/#ixzz21IvfBErX
Searching for health beneficial n-3 and n-6 fatty acids in plant seeds (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3380567/?toolubmed
Archaeobotanical study of ancient food and cereal remains at the Astana cemeteries, Xinjiang, China (full-2012) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0045137
Nutritive quality of romanian hemp varieties (Cannabis sativa L) with special focus on oil and metal contents of seeds (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3543203/
top
Effect of feeding hemp seed and hemp seed oil on laying hen performance and egg yolk fatty acid content: Evidence of their safety and efficacy for laying hen diets (full–2012) http://ps.oxfordjournals.org/content/91/3/701.long
Comparative Study of Sedation, Pre-Anesthetic and Anti-Anxiety Effects of Hemp Seed Extract and Diazepam in Rats (full–2012) http://docsdrive.com/pdfs/medwelljournals/javaa/2012/2148-2151.pdf
Hemp Food Storage (article–2012) http://www.innvista.com/health/foods/hemp/hemp-food-storage/
Hemp Seed Protein (article–2012) http://www.innvista.com/foods/hemp/hemp-seed-protein/
Hemp Seeds (article–2012) http://www.innvista.com/foods/hemp/hemp-seeds/
Hemp Seeds as Medicine (article–2012) http://www.innvista.com/foods/hemp/hemp-seeds-as-medicine/
Proteomic profiling of hempseed proteins from Cheungsam (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22040604
atty Acid Profile and Sensory Characteristics of Table Eggs from Laying Hens Fed Hempseed and Hempseed Oil (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22429187
The isolation and identification of two compounds with predominant radical scavenging activity in hempseed (seed of Cannabis sativa L) (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/23107724
Agents that act luminally to treat diarrhoea and constipation. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22945441
6 Power Foods You Should Be Eating – Hemp Seed (news-2012) http://www.menshealth.com/mhlists/essential_power_foods/Power_Food_Hemp_Seeds.php
Association of Expanded Disability Status Scale and Cytokines after Intervention with Co-supplemented Hemp Seed, Evening Primrose Oils and Hot-natured Diet in Multiple Sclerosis Patients (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3648912/
Preventive and treatment effects of a hemp seed (Cannabis sativa L) meal protein hydrolysate against high blood pressure in spontaneously hypertensive rats (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/24292743
Are Hemp Seeds Part of a Healthy Diet? (news-2013) http://www.wakingtimes.com/2013/03/29/are-hemp-seeds-part-of-a-healthy-diet/
Herbal medicine may ease constipation (news-2013) http://www.lifescript.com/health/centers/pain/alternative_treatments/traditional_chinese_herbal_medicine_articles/herbal_medicine_may_ease_constipation.aspx
Chew on This: Hemp is the New Health Food (news-2013) http://www.lifescript.com/food/healthy_eating_guides/dinner/articles/chew_on_this_hemp_is_the_new_health_food.aspx
Hemp Prepares for Prime Time as Weed’s Sober Cousin (news-2014) http://finance.yahoo.com/news/hemp-prepares-prime-time-weed-071616416.html;_ylt=AwrTWfzp93xTkEoADafQtDMD
top
Plant-Based Foods With the Highest Omega-3 Fatty Acids (news-2014) http://www.onegreenplanet.org/natural-health/plant-based-foods-with-the-highest-amount-of-omega-3-fatty-acids/
High on the menu: cannabis spaghetti features at Italian foodfest (news-2015) http://news.yahoo.com/high-menu-cannabis-spaghetti-features-italian-foodfest-171918733–sector.html;_ylt=AwrC1CoQM7BV3D8A4UzQtDMD;_ylu=X3oDMTBydDI5cXVuBGNvbG8DYmYxB
HBvcwM2BHZ0aWQDBHNlYwNzcg–‘Protein powder’ claim required evidence in drug driving case, court rules (news-2015) http://www.canberratimes.com.au/act-news/protein-powder-claim-required-evidence-in-drug-driving-casecourt-rules-20150731-giolit.html#ixzz3hgXHnNjt
Hemp for a Healthy Heart? (news-2015) http://blog.lifeextension.com/2014/02/hemp-for-healthy-heart.html
The Benefits of Organic Hemp Milk (news-2015) http://www.globalhealingcenter.com/natural-health/benefits-of-hemp-milk/


NUTRITION-HEMP SEED OIL
Hemp Oil Compared to Flax Oil (article-2010) http://www.ehow.com/facts_7639247_hemp-oil-compared-flax-oil.html
QUALITY OF HEMP SEED OIL DEPENDING ON ITS OBTAINING (abst-2010) http://www.potravinarstvo.com/journal1/index.php/potravinarstvo/article/view/32/pdf
Evaluating the quality of protein from hemp seed (Cannabis sativa L) products through the use of the protein digestibility-corrected amino acid score method (abst-2010) http://www.ncbi.nlm.nih.gov/pubmed/20977230
Analytical Characterization of Hempseed (Seed of Cannabis sativa L) Oil from Eight Regions in China (abst-2010) http://www.ncbi.nlm.nih.gov/pubmed/22435611
Hemp Seed Oil for Skin (news-2010) http://www.livestrong.com/article/340189-hemp-seed-oil-for-skin/
The Benefits of Hemp Oil on Hair (news-2010) http://www.livestrong.com/article/189783-the-benefits-of-hemp-oil-on-hair/
Vets use hemp seed oil on animals with cancer (news-2010) http://www.examiner.com/x-33448-LA-County-Environmental-News-Examiner~y2010m3d22-Vets-usehemp-seed-oil-on-animals-with-cancer
top
Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21278728
Anchovy red wine vinegarette with or without cannabis oil (news-2011) http://www.examiner.com/chef-about-town-in-seattle/recipes-that-make-lives-easier-anchovy-red-winevinegarette-with-or-wi
Hemp Oil Vs. Flax Oil (2) (news-2011) http://www.livestrong.com/article/413750-hemp-oil-vs-flax-oil/
Searching for health beneficial n-3 and n-6 fatty acids in plant seeds (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3380567/
Antioxidant Activities and Oxidative Stabilities of Some Unconventional Oilseeds (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3311859/?toolubmed
Effect of feeding hemp seed and hemp seed oil on laying hen performance and egg yolk fatty acid content: Evidence of their safety and efficacy for laying hen diets (full-2012) http://ps.oxfordjournals.org/content/91/3/701.long
Fatty Acid Profile and Sensory Characteristics of Table Eggs from Laying Hens Fed Hempseed and Hempseed Oil (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22429187
Hemp Seed Oil For Eczema – Cures From The Inside Out (news/anecdotal-2012) http://www.theweedblog.com/hemp-seed-oil-for-eczema-cures-from-the-inside-out/
Hemp (Cannabis sativa L) seed oil: Analytical and phytochemical characterization of unsaponifiable fraction (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24422510
Effects of Hemp (Cannabis sativa L) Seed Oil Press-Cake and Decaffeinated Green Tea Leaves (Camellia sinensis) on Functional Characteristics of Gluten-Free Crackers (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24527987
Potential Oil Yield, Fatty Acid Composition, and Oxidation Stability of the Hempseed Oil from Four Cannabis sativa L. Cultivars (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24552275
Hempseed oil induces reactive oxygen species- and C/EBP homologous protein-mediated apoptosis in MH7A human rheumatoid arthritis fibroblast-like synovial cells (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24814038
Cannabinoid-free Cannabis sativa L. grown in the Po valley: evaluation of fatty acid profile, antioxidant capacity and metabolic content (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24934168
Targeted mutation of Δ12 and Δ15 desaturase genes in hemp produce major alterations in seed fatty acid composition including a high oleic hemp oil (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24506492
Hempseed oil has healthy potential: study (news–2014) http://news.yahoo.com/hempseed-oil-healthy-potential-study-195140602.html
How to Give Yourself a Cannabis Facial (news-2014) http://www.elle.com/the-pot-issue/hemp-facial-diy
Effect of ultrasound pre-treatment of hemp (Cannabis sativa L) seed on supercritical CO2 extraction of oil (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25745251
Stability of cosmetic emulsion containing different amount of hemp oil (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25704610
top